Company Overview
B-Bridge International, Inc.
Established in 2000 by Hiro Masumoto, B-Bridge is a California company headquartered in Cupertino, California—south of San Francisco
B-Bridge International is an expert in bringing innovation to market. Acting as a "bridge" between developers and entrepreneurs, B-Bridge provides critical connections and expertise to transform new discoveries into tangible and useful tools that improve quality of life. B-Bridge facilitates effective partnerships between developers, researchers, manufacturers, and suppliers, by building synergy through business development, licensing and development partnerships.
B-Bridge is lead by a team of experts in the life science reagent market, with a proven track record of bringing innovative life science research tools developed in one corner of the globe to the rest of the world. B-Bridge has the expertise, resources, and business channels to bring research tools from around the world, including emerging markets like China and India, to researchers in Asia, Europe, and Americas. For over a decade, B-Bridge has assisted researchers in tackling important problems in medicine and biology.
Company History
- February 2000:B-Bridge International, Inc. founded
- February 2001:Moved into 4320 Stevens Creek Blvd San Jose CA
- October 2001:Signed contract with Dharmacon for Japan Distribution
- June 2002:Launched the Otsuka's Adiponectin ELISA Kit (the first commercially available Adiponectin assay)
- July 2002:Started B-Bridge RNAi consortium in Japan
- January 2003:Helped DRCA Gel Electrophoresis system establish US subsidiary
- February 2003:Co-founded Avocel with Stanford Professor Mark Kay
- August 2003:Company moved to 639 N.Pastoria Ave. Sunnyvale CA
- October 2003:Co-founded STREX Mechanical Cell Strain Company
- May 2004:Avocell purchased by Benitec Ltd.
- September 2004:BioSite Capital bio-incubation partner agreement
- November 2004:Launch siSolutions siRNA Products
- December 2004:Hokkaido Venture Capital bio-incubation partner agreement
- December 2004:Signed to distribute DiscoveRx in Japan
- March 2005:$4.3 million additional investment-lead investors Hokkaido Venture Capital, BioSite Capital, and the Marubeni Corporation
- November 2005:BayMode partnership to distribute books and technical journals
- March 2006:Bioincubation partnership with Japanese External Trade Resource Organization (JETRO) and established bioincubator facility.
- May 2006:Company moved to 320 Logue Ave., Mountain View, CA
- December 2006:BayMode acquisition
- April 2007:Established B-Bridge Subsidiary in Tokyo, B-Bridge K.K.
- June 2007:Additional $1M investment from the Marubeni Corporation
- October 2007:Partnership with Kanazawa Technology Licensing Office
- February 2008:Collaboration agreement with Neurosky
- March 2008:Partnership with MSA Partners LLC
- April 2008:Hiro Masumoto becomes managing partner in Global Innovators
- October 2008:Partnership with Kansai Technology Licensing Office
- January 2009:Hiro Masumoto becomes General Manager of Intertrust Management
- June 2009:B-Bridge Technology Transfer Site launched